Skip Navigation


Europace Advance Access originally published online on October 28, 2009
Europace 2009 11(12):1639-1646; doi:10.1093/europace/eup314
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
11/12/1639    most recent
eup314v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Europace
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pascale, P.
Right arrow Articles by Fromer, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pascale, P.
Right arrow Articles by Fromer, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.


Implantable Cardioverter-Defibrillators

Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization{dagger}

Patrizio Pascale1,*, Jürg Schlaepfer1, Mauro Oddo2, Marie-Denise Schaller2, Pierre Vogt1 and Martin Fromer1

1 Service of Cardiology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, 1011 Lausanne, Switzerland; 2 Intensive Care Unit, Centre Hospitalier Universitaire Vaudois, University of Lausanne, 1011 Lausanne, Switzerland

Aims: Estimates of the left ventricular ejection fraction (LVEF) in patients with life-threatening ventricular arrhythmias related to coronary artery disease (CAD) have rarely been reported despite it has become the basis for determining patient's eligibility for prophylactic defibrillator. We aimed to determine the extent and distribution of reduced LVEF in patients with sustained ventricular tachycardia or ventricular fibrillation.

Methods and results: 252 patients admitted for ventricular arrhythmia related to CAD were included: 149 had acute myocardial infarction (MI) (Group I, 59%), 54 had significant chronic obstructive CAD suggestive of an ischaemic arrhythmic trigger (Group II, 21%) and 49 patients had an old MI without residual ischaemia (Group III, 19%). 34% of the patients with scar-related arrhythmias had an LVEF ≥40%. Based on pre-event LVEF evaluation, it can be estimated that less than one quarter of the whole study population had a known chronic MI with severely reduced LVEF. In Group III, the proportion of inferior MI was significantly higher than anterior MI (81 vs. 19%; absolute difference, –62; 95% confidence interval, –45 to –79; P ≤ 0.0001), though median LVEF was higher in inferior MI (0.37 ± 10 vs. 0.29 ± 10; P = 0.0499).

Conclusion: Patients included in defibrillator trials represent only a minority of the patients at risk of sudden cardiac death. By applying the current risk stratification strategy based on LVEF, more than one third of the patients with old MI would not have qualified for a prophylactic defibrillator. Our study also suggests that inferior scars may be more prone to ventricular arrhythmia compared to anterior scars.

Key Words: Ventricular arrhythmia, Myocardial infarction, Sudden death, Arrhythmic risk, Ejection fraction


* Corresponding author. Tel: +41 213140069, Fax: +41 213140013, Email: patrizio.pascale{at}chuv.ch

{dagger} Presented in part at the 56th annual scientific session of the American College of Cardiology in New Orleans, LA, March 2007.

Manuscript submitted 29 July 2009. Accepted after revision 16 September 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Europace:

Implantable cardioverter-defibrillator therapy and the total burden of sudden cardiac death
Heikki V. Huikuri
Europace 2009 11: 1574. [Full Text]  



This article has been cited by other articles:


Home page
EuropaceHome page
H. V. Huikuri
Implantable cardioverter-defibrillator therapy and the total burden of sudden cardiac death
Europace, December 1, 2009; 11(12): 1574 - 1574.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.